# Early phase 1 glioma trials recruiting: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in early phase 1 for glioma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Early phase 1 glioma trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/early-phase-1/glioma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 25, 2026 | NCT07784985 | A Study of NST-628 in Recurrent Grade 4 Glioma | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | Glioma, Recurrent High Grade, Grade 4 Malignant Glioma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784985) |
| August 24, 2026 | NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | Lumina Pharmaceuticals Inc | Early phase 1 | Not yet recruiting | Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781852) |
| August 21, 2026 | NCT07778979 | Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas | University of Alabama at Birmingham | Early phase 1 | Not yet recruiting | Glioma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778979) |
| June 10, 2026 | NCT07639970 | Evaluation of \[⁶⁸Ga/¹⁷⁷Lu\]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | Breast Cancer, Head and Neck Cancer (H&N), Pancreatic Cancer, Glioma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639970) |
| June 5, 2026 | NCT07628634 | Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors | University of California, Irvine | Early phase 1 | Recruiting | Adenocarcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Ductal Carcinoma... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628634) |
| October 7, 2025 | NCT07210632 | Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Brain Cancer, HGG, Glioma, High Grade Glioma, High Grade Gliomas, High Grade Glioma (III or IV), High Grade Glioma... | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07210632) |
| July 22, 2025 | NCT07077616 | Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly... | Biogenea Pharmaceuticals Ltd. | Early phase 1 | Recruiting | Glioma | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07077616) |
| June 17, 2025 | NCT07025226 | Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously... | Mayo Clinic | Early phase 1 | Recruiting | Glioma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07025226) |
| February 17, 2025 | NCT06829173 | Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas | NYU Langone Health | Early phase 1 | Recruiting | High-Grade Glioma | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06829173) |
| October 10, 2024 | NCT06636162 | Window of Opportunity Study of DSP-0390 in Gliomas | Washington University School of Medicine | Early phase 1 | Recruiting | Glioma, Malignant, IDH Mutation | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06636162) |
| May 2, 2024 | NCT06396481 | Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma | Beijing Tiantan Hospital | Early phase 1 | Not yet recruiting | GBM, DIPG Brain Tumor, Medulloblastoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06396481) |
| March 27, 2024 | NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | Nationwide Children's Hospital | Early phase 1 | Recruiting | High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Infant Type Hemispheric Glioma... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06333899) |
| October 10, 2023 | NCT06072586 | A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR... | St. Joseph's Hospital and Medical Center, Phoenix | Early phase 1 | Recruiting | High Grade Glioma, Glioblastoma | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06072586) |
| April 7, 2023 | NCT05804227 | Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas | M.D. Anderson Cancer Center | Early phase 1 | Recruiting | Gliomas | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05804227) |
| February 8, 2023 | NCT05717153 | Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma | Mayo Clinic | Early phase 1 | Recruiting | Diffuse Glioma, Malignant Glioma | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05717153) |
| January 9, 2023 | NCT05676489 | MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors | University of Alabama at Birmingham | Early phase 1 | Not yet recruiting | Healthy Volunteers, Recurrent Glioma, Brain Metastases From Extra-cranial Solid Tumors | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05676489) |
| November 30, 2022 | NCT05632562 | Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma | University of Alabama at Birmingham | Early phase 1 | Recruiting | High Grade Glioma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05632562) |
| September 27, 2022 | NCT05555550 | Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG | Children's Hospital of Philadelphia | Early phase 1 | Recruiting | Glioma, Low-grade Glioma, Low Grade Glioma of Brain, Glioma, Malignant, Glioma Intracranial | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05555550) |
| September 23, 2022 | NCT05553041 | 18F-Fluciclovine PET-MRI in High-grade Glioma | Children's Hospital of Philadelphia | Early phase 1 | Recruiting | Glioma, High Grade Glioma, Glioma, Malignant, Glioma Intracranial, Diffuse Glioma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05553041) |
| June 29, 2021 | NCT04943913 | Study of GC101 TIL in Brain Glioma (Soochow2) | Shanghai Juncell Therapeutics | Early phase 1 | Recruiting | Glioma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04943913) |
| December 4, 2018 | NCT03763396 | Azoles Targeting Recurrent High Grade Gliomas | University Health Network, Toronto | Early phase 1 | Not yet recruiting | Brain Tumor, Recurrent, Cancer, Advanced, Glioma of Brain | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03763396) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Alabama at Birmingham | 3 |
| Mayo Clinic | 2 |
| Children's Hospital of Philadelphia | 2 |
| University of California, Irvine | 1 |
| Washington University School of Medicine | 1 |
| Biogenea Pharmaceuticals Ltd. | 1 |
| NYU Langone Health | 1 |
| Nationwide Children's Hospital | 1 |
| Shanghai Juncell Therapeutics | 1 |
| St. Joseph's Hospital and Medical Center, Phoenix | 1 |
| M.D. Anderson Cancer Center | 1 |
| University Health Network, Toronto | 1 |
| Lumina Pharmaceuticals Inc | 1 |
| Beijing Tiantan Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 16 |
| Canada | 2 |
| China | 2 |
| Greece | 1 |
| Australia | 1 |
| Germany | 1 |
| Netherlands | 1 |
| New Zealand | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
- [Israeli restaurants in the United States](https://specstream.ai/data/businesses/israeli-restaurants/united-states)
- [Dumpster rental companies in the United States](https://specstream.ai/data/businesses/dumpster-rental-companies/united-states)
- [B2B marketing consultants in the United States](https://specstream.ai/data/businesses/b2b-marketing-consultants/united-states)
- [Sports bars in the United States](https://specstream.ai/data/businesses/sports-bars/united-states)
- [Nephrology practices in the United States](https://specstream.ai/data/businesses/nephrology-practices/united-states)
